0000886163-22-000125.txt : 20220922 0000886163-22-000125.hdr.sgml : 20220922 20220922203250 ACCESSION NUMBER: 0000886163-22-000125 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220916 FILED AS OF DATE: 20220922 DATE AS OF CHANGE: 20220922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIGGINS JOHN L CENTRAL INDEX KEY: 0001208906 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 221260442 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4/A 1 edgardoc.xml PRIMARY DOCUMENT X0306 4/A 2022-09-16 2022-09-16 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001208906 HIGGINS JOHN L 5980 HORTON STREET, SUITE 405 EMERYVILLE CA 94608 1 1 0 0 Chief Executive Officer Common Stock 2022-09-16 4 S 0 1000 88.06 D 366180 D On September 16, 2022, due to an issue with the equity administration system of the company, the reporting person filed a Form 4 which inadvertently reported the sale of a higher number of shares than were actually sold by the reporting person. The correct number of shares sold is listed above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.05 to $88.12, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. By: Charles S. Berkman For: John L. Higgins 2022-09-22